Bioinformatic analyses and conceptual synthesis of evidence linking ZNF804A to risk for schizophrenia and bipolar disorder

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 168, Issue 1, 2015, Pages 14-35

  Hess, Jonathan L ^a   Quinn, Thomas P ^a   Akbarian, Schahram ^b   Glatt, Stephen J ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Alternative splicing; Bioinformatics; Bipolar disorder; Epigenetics; Microarray; Protein model; RNA sequencing; Rs1344706; Schizophrenia; ZNF804A

Indexed keywords

UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 804 A; KRUPPEL LIKE FACTOR; ZNF804A PROTEIN, HUMAN;

ALTERNATIVE RNA SPLICING; BIOINFORMATICS; BIPOLAR DISORDER; BLOOD; BRAIN; COMPUTER MODEL; EPIGENETICS; EPISTASIS; EXON; GENE EXPRESSION; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MOLECULAR GENETICS; NEUROPATHOLOGY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SCHIZOPHRENIA; BIOLOGY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; SINGLE NUCLEOTIDE POLYMORPHISM;

ALTERNATIVE SPLICING; BIPOLAR DISORDER; COMPUTATIONAL BIOLOGY; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 84919458558     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32284     Document Type: Review

References (79)

1. Adkins NL, Hagerman TA, Georgel P. 2006. GAGA protein: A multi-faceted transcription factor. Biochem Cell Biol 84:559-567.
2. Balog Z, Kiss I, Kéri S. 2011. ZNF804A may be associated with executive control of attention. Genes Brain Behav 10:223-227.
3. Bergmann O, Haukvik UK, Brown A a, Rimol LM, Hartberg CB, Athanasiu L, Melle I, Djurovic S, Andreassen O a, Dale AM, Agartz I. 2013. ZNF804A and cortical thickness in schizophrenia and bipolar disorder. Psychiatry Res 212:154-157.
4. Bernstein BE, Stamatoyannopoulos JA, Costello JF, Ren B, Milosavljevic A, Meissner A, Kellis M, Marra MA, Beaudet AL, Ecker JR, Farnham PJ, Hirst M, Lander ES, Mikkelsen TS, Thomson JA. 2010. The NIH Roadmap Epigenomics Mapping Consortium. Nat Biotechnol 28:1045-1048.
5. Bertolino A, Fazio L, Caforio G, Blasi G, Rampino A, Romano R, Di Giorgio A, Taurisano P, Papp A, Pinsonneault J, Wang D, Nardini M, Popolizio T, Sadee W. 2009. Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia. Brain 132:417-425.
6. Bertolino A, Knable MB, Saunders RC, Callicott JH, Kolachana B, Mattay VS, Bachevalier J, Frank JA, Egan M, Weinberger DR. 1999. The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia. Biol Psychiatry 45:660-667.
7. Bora E, Pantelis C. 2013. Theory of mind impairments in first-episode psychosis, individuals at ultra-high risk for psychosis and in first-degree relatives of schizophrenia: systematic review and meta-analysis. Schizophr Res 144:31-36.
8. Bora E, Yücel M, Pantelis C. 2009. Theory of mind impairment: a distinct trait-marker for schizophrenia spectrum disorders and bipolar disorder. Acta Psychiatr Scand 120:253-264.
9. Bousman CA, Chana G, Glatt SJ, Chandler SD, Lucero GR, Tatro E, May T, Lohr JB, Kremen WS, Tsuang MT, Everall IP. 2010. Preliminary evidence of ubiquitin proteasome system dysregulation in schizophrenia and bipolar disorder: Convergent pathway analysis findings from two independent samples. Am J Med Genet B Neuropsychiatr Genet 153B:494-502.
10. Brennand KJ, Simone A, Jou J, Gelboin-Burkhart C, Tran N, Sangar S, Li Y, Mu Y, Chen G, Yu D, McCarthy S, Sebat J, Gage FH. 2011. Modelling schizophrenia using human induced pluripotent stem cells. Nature 473:221-225.
11. Buonocore F, Hill MJ, Campbell CD, Oladimeji PB, Jeffries AR, Troakes C, Hortobagyi T, Williams BP, Cooper JD, Bray NJ. 2010. Effects of cis-regulatory variation differ across regions of the adult human brain. Hum Mol Genet 19:4490-4496.
12. Chen C, Cheng L, Grennan K, Pibiri F, Zhang C, Badner JA, Gershon ES, Liu C. 2013. Two gene co-expression modules differentiate psychotics and controls. Mol Psychiatry 18:1308-1314.
13. Chen M, Xu Z, Zhai J, Bao X, Zhang Q, Gu H, Shen Q, Cheng L, Chen X, Wang K, Deng X, Ji F, Liu C, Li J, Dong Q, Chen C. 2012. Evidence of IQ-modulated association between ZNF804A gene polymorphism and cognitive function in schizophrenia patients. Neuropsychopharmacology 37:1572-1578.
14. Colantuoni C, Lipska BK, Ye T, Hyde TM, Tao R, Leek JT, Colantuoni EA, Elkahloun AG, Herman MM, Weinberger DR, Kleinman JE. 2011. Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 478:519-523.
15. Cousijn H, Rijpkema M, Harteveld A, Harrison PJ, Fernandez G, Franke B, Arias-Vasquez A. 2012. Schizophrenia risk gene ZNF804A does not influence macroscopic brain structure: An MRI study in 892 volunteers. Mol Psychiatry 17:1155-1157.
16. Del Re EC, Bergen SE, Mesholam-Gately RI, Niznikiewicz MA, Goldstein JM, Woo TU, Shenton ME, Seidman LJ, McCarley RW, Petryshen TL. 2014. Analysis of schizophrenia-related genes and electrophysiological measures reveals ZNF804A association with amplitude of P300b elicited by novel sounds. Transl Psychiatry 4:e346.
17. Esslinger C, Kirsch P, Haddad L, Mier D, Sauer C, Erk S, Schnell K, Arnold C, Witt SH, Rietschel M, Cichon S, Walter H, Meyer-Lindenberg A. 2011. Cognitive state and connectivity effects of the genome-wide significant psychosis variant in ZNF804A. Neuroimage 54:2514-2523.
18. Fernø J, Skrede S, Vik-Mo AO, Håvik B, Steen VM. 2006. Drug-induced activation of SREBP-controlled lipogenic gene expression in CNS-related cell lines: Marked differences between various antipsychotic drugs. BMC Neurosci 7:69.
19. Fietz SA, Lachmann R, Brandl H, Kircher M, Samusik N, Schröder R, Lakshmanaperumal N, Henry I, Vogt J, Riehn A, Distler W, Nitsch R, Enard W, Pääbo S, Huttner WB. 2012. Transcriptomes of germinal zones of human and mouse fetal neocortex suggest a role of extracellular matrix in progenitor self-renewal. Proc Natl Acad Sci USA 109:11836-11841.
20. Garriock HA, Kraft JB, Shyn SI, Peters EJ, Yokoyama JS, Jenkins GD, Reinalda MS, Slager SL, McGrath PJ, Hamilton SP. 2010. A genomewide association study of citalopram response in major depressive disorder. Biol Psychiatry 67:133-138.
21. Girgenti MJ, LoTurco JJ, Maher BJ. 2012. ZNF804a regulates expression of the schizophrenia-associated genes PRSS16, COMT, PDE4B, and DRD2. PLoS ONE 7:e32404.
22. Guella I, Sequeira A, Rollins B, Morgan L, Torri F, van Erp TGM, Myers RM, Barchas JD, Schatzberg AF, Watson SJ, Akil H, Bunney WE, Potkin SG, Macciardi F, Vawter MP. 2013. Analysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex. J Psychiatr Res 47:1215-1221.
23. Guella I, Sequeira A, Rollins B, Morgan L, Myers RM, Watson SJ, Akil H, Bunney WE, Delisi LE, Byerley W, Vawter MP. 2014. Evidence of allelic imbalance in the schizophrenia susceptibility gene ZNF 804A in human dorsolateral prefrontal cortex. Schizophr Res 152(1):111-116.
24. Guella I, Vawter MP. 2014. Allelic imbalance associated with the schizophrenia risk SNP rs1344706 indicates a cis-acting variant in ZNF804A. Schizophr Res 153(1-3):243-245.
25. Hashimoto R, Ohi K, Yasuda Y, Fukumoto M, Iwase M, Iike N, Azechi M, Ikezawa K, Takaya M, Takahashi H, Yamamori H, Okochi T, Tanimukai H, Tagami S, Morihara T, Okochi M, Tanaka T, Kudo T, Kazui H, Iwata N, Takeda M. 2010. The impact of a genome-wide supported psychosis variant in the ZNF804A gene on memory function in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 153B:1459-1464.
26. Hayes PL, Lytle BL, Volkman BF, Peterson FC. 2008. The solution structure of ZNF593 from Homo sapiens reveals a zinc finger in a predominately unstructured protein. Protein Sci 17(3): 571-576.
27. Hess JL, Glatt SJ. 2014. How might ZNF804A variants influence risk for schizophrenia and bipolar disorder? A literature review, synthesis, and bioinformatic analysis. Am J Med Genet B Neuropsychiatr Genet 165:28-40.
28. Hill MJ, Bray NJ. 2011. Allelic differences in nuclear protein binding at a genome-wide significant risk variant for schizophrenia in ZNF804A. Mol Psychiatry 16:787-789.
29. Hill MJ, Bray NJ. 2012. Evidence that schizophrenia risk variation in the ZNF804A gene exerts its effects during fetal brain development. Am J Psychiatry 169:1301-1308.
30. Hill MJ, Jeffries AR, Dobson RJ, Price J, Bray NJ. 2012. Knockdown of the psychosis susceptibility gene ZNF804A alters expression of genes involved in cell adhesion. Hum Mol Genet 21:1018-1024.
31. Houston I, Peter CJ, Mitchell A, Straubhaar J, Rogaev E, Akbarian S. 2013. Epigenetics in the human brain. Neuropsychopharmacology 38:183-197.
32. Ira E, Zanoni M, Ruggeri M, Dazzan P, Tosato S. 2013. COMT, neuropsychological function and brain structure in schizophrenia: A systematic review and neurobiological interpretation. J Psychiatry Neurosci 38:366-380.
33. Iuchi S. 2001. Three classes of C 2 H 2 zinc finger proteins. Cell Mol Life Sci 58:625-635.
34. Jiang L, Schlesinger F, Davis CA, Zhang Y, Li R, Salit M, Gingeras TR, Oliver B. 2011. Synthetic spike-in standards for RNA-seq experiments. Genome Res 21:1543-1551.
35. Kelley L a, Sternberg MJE. 2009. Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc 4:363-371.
36. Kim AH, Parker EK, Williamson V, McMichael GO, Fanous AH, Vladimirov VI. 2012. Experimental validation of candidate schizophrenia gene ZNF804A as target for hsa-miR-137. Schizophr Res 141:60-64.
37. Kuswanto CN, Woon P-S, Zheng X, Bin Qiu, Sitoh Y-Y, Chan YH, Liu J, Williams H, Ong WY, Sim K. 2012. Genome-wide supported psychosis risk variant in ZNF804A gene and impact on cortico-limbic WM integrity in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 159B:255-262.
38. Langfelder P, Horvath S. 2008. WGCNA: An R package for weighted correlation network analysis. BMC Bioinformatics 9:559.
39. Lee SH, DeCandia TR, Ripke S, Yang J, Sullivan PF, Goddard ME, Keller MC, Visscher PM, Wray NR. 2012a. Estimating the proportion of variation in susceptibility to schizophrenia captured by common SNPs. Nat Genet 44:247-250.
40. Lee Y, Mattai A, Long R, Rapoport JL, Gogtay N, Addington AM. 2012b. Microduplications disrupting the MYT1L gene (2p25.3) are associated with schizophrenia. Psychiatr Genet 22:206-209.
41. Lee SH, Ripke, Neale SBM, Faraone SV, Purcell SM, Perlis RH, Mowry BJ, Thapar A, Goddard ME, Witte JS, Absher D, Agartz I, Akil H, Amin F, Andreassen OA, Anjorin A, Anney R, Anttila V, Arking DE, Asherson P, Azevedo MH, Backlund L, Badner JA, Bailey AJ, Banaschewski T, Barchas JD, Barnes MR, Barrett TB, Bass N, Battaglia A, Bauer M, Bayes M, Bellivier F, Bergen SE, Berrettini W, Betancur C, Bettecken T, Biederman J, Binder EB, Black DW, Blackwood DH, Bloss CS, Boehnke M, Boomsma DI, Breen G, Breuer R, Bruggeman R, Cormican P, Buccola NG, Buitelaar JK, Bunney WE, Buxbaum JD, Byerley WF, Byrne EM, Caesar S, Cahn W, Cantor RM, Casas M, Chakravarti A, Chambert K, Choudhury K, Cichon S, Cloninger CR, Collier DA, Cook EH, Coon H, Cormand B, Corvin A, Coryell WH, Craig DW, Craig IW, Crosbie J, Cuccaro ML, Curtis D, Czamara D, Datta S, Dawson G, Day R, De Geus EJ, Degenhardt F, Djurovic S, Donohoe GJ, Doyle AE, Duan J, Dudbridge F, Duketis E, Ebstein RP, Edenberg HJ, Elia J, Ennis S, Etain B, Fanous A, Farmer AE, Ferrier IN, Flickinger M, Fombonne E, Foroud T, Frank J, et al. 2013. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet 45(9):984-994.
42. Li M, Zhang H, Luo X, Gao L, Qi X, Gourraud P-A, Su B. 2013. Meta-analysis indicates that the European GWAS-identified risk SNP rs1344706 within ZNF804A is not associated with schizophrenia in Han Chinese population. PLoS ONE 8:e65780.
43. Li W, Wang X, Zhao J, Lin J, Song X-Q, Yang Y, Jiang C, Xiao B, Yang G, Zhang H-X, Lv L-X. 2012. Association study of myelin transcription factor 1-like polymorphisms with schizophrenia in Han Chinese population. Genes Brain Behav 11:87-93.
44. Marsh L, Suddath RL, Higgins N, Weinberger DR. 1994. Medial temporal lobe structures in schizophrenia: relationship of size to duration of illness. Schizophr Res 11:225-238.
45. Miller BH, Zeier Z, Xi L, Lanz TA, Deng S, Strathmann J, Willoughby D, Kenny PJ, Elsworth JD, Lawrence MS, Roth RH, Edbauer D, Kleiman RJ, Wahlestedt C. 2012. MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function. Proc Natl Acad Sci USA 109:3125-3130.
46. Mohnke S, Erk S, Schnell K, Schütz C, Seiferth N, Grimm O, Haddad L, Pöhland L, Garbusow M, Schmitgen MM, Kirsch P, Esslinger C, Rietschel M, Witt SH, Nöthen MM, Cichon S, Mattheisen M, Mühleisen T, Jensen J, Schott BH, Maier W, Heinz A, Meyer-Lindenberg A, Walter H. 2013. Further Evidence for The Impact of a Genome-Wide Supported Psychosis Risk Variant in ZNF804A on The Theory of Mind Network. Neuropsychopharmacology 39(5):1196-1205.
47. Mössner R, Schuhmacher A, Wagner M, Lennertz L, Steinbrecher A, Quednow BB, Rujescu D, Rietschel M, Maier W. 2012. The schizophrenia risk gene ZNF804A influences the antipsychotic response of positive schizophrenia symptoms. Eur Arch Psychiatry Clin Neurosci 262:193-197.
48. O'Donoghue T, Morris DW, Fahey C, Da Costa A, Moore S, Cummings E, Leicht G, Karch S, Hoerold D, Tropea D, Foxe JJ, Gill M, Corvin A, Donohoe G. 2014. Effects of ZNF804A on auditory P300 response in schizophrenia. Transl Psychiatry 4:e345.
49. O'Donovan MC, Craddock N, Norton N, Williams H, Peirce T, Moskvina V, Nikolov I, Hamshere M, Carroll L, Georgieva L, Dwyer S, Holmans P, Marchini JL, Spencer CC, Howie B, Leung HT, Hartmann AM, Moller HJ, Morris DW, Shi Y, Feng G, Hoffmann P, Propping P, Vasilescu C, Maier W, Rietschel M, Zammit S, Schumacher J, Quinn EM, Schulze TG, Williams NM, Giegling I, Iwata N, Ikeda M, Darvasi A, Shifman S, He L, Duan J, Sanders AR, Levinson DF, Gejman PV, Cichon S, Nothen MM, Gill M, Corvin A, Rujescu D, Kirov G, Owen MJ, Buccola NG, Mowry BJ, Freedman R, Amin F, Black DW, Silverman JM, Byerley WF, Cloninger CR. 2008. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 40:1053-1055.
50. Paulus FM, Krach S, Bedenbender J, Pyka M, Sommer J, Krug A, Knake S, Nothen MM, Witt SH, Rietschel M, Kircher T, Jansen A. 2013. Partial support for ZNF804A genotype-dependent alterations in prefrontal connectivity. Hum Brain Mapp 34:304-313.
51. Pedone PV, Ghirlando R, Clore GM, Gronenborn a, Felsenfeld G, Omichinski JG. 1996. The single Cys2-His2 zinc finger domain of the GAGA protein flanked by basic residues is sufficient for high-affinity specific DNA binding. Proc Natl Acad Sci USA 93:2822-2826.
52. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, Maller J, Sklar P, de Bakker PIW, Daly MJ, Sham PC. 2007. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559-575.
53. Rasetti R, Sambataro F, Chen Q, Callicott JH, Mattay VS, Weinberger DR. 2011. Altered cortical network dynamics: a potential intermediate phenotype for schizophrenia and association with ZNF804A. Arch Gen Psychiatry 68:1207-1217.
54. Riley B, Thiselton D, Maher BS, Bigdeli T, Wormley B, McMichael GO, Fanous AH, Vladimirov V, O'Neill FA, Walsh D, Kendler KS. 2010. Replication of association between schizophrenia and ZNF804A in the Irish Case-Control Study of Schizophrenia sample. Mol Psychiatry 15:29-37.
55. Ripke S, O'Dushlaine C, Chambert K, Moran JL, Kähler AK, Akterin S, Bergen SE, Collins AL, Crowley JJ, Fromer M, Kim Y, Lee SH, Magnusson PKE, Sanchez N, Stahl Ea, Williams S, Wray NR, Xia K, Bettella F, Borglum AD, Bulik-Sullivan BK, Cormican P, Craddock N, de Leeuw C, Durmishi N, Gill M, Golimbet V, Hamshere ML, Holmans P, Hougaard DM, Kendler KS, Lin K, Morris DW, Mors O, Mortensen PB, Neale BM, O'Neill Fa, Owen MJ, Milovancevic MP, Posthuma D, Powell J, Richards AL, Riley BP, Ruderfer D, Rujescu D, Sigurdsson E, Silagadze T, Smit AB, Stefansson H, Steinberg S, Suvisaari J, Tosato S, Verhage M, Walters JT, Levinson DF, Gejman PV, Laurent C, Mowry BJ, O'Donovan MC, Pulver AE, Schwab SG, Wildenauer DB, Dudbridge F, Shi J, Albus M, Alexander M, Campion D, Cohen D, Dikeos D, Duan J, Eichhammer P, Godard S, Hansen M, Lerer FB, Liang K-Y, Maier W, Mallet J, Nertney Da, Nestadt G, Norton N, Papadimitriou GN, Ribble R, Sanders AR, Silverman JM, Walsh D, Williams NM, Wormley B, Arranz MJ, Bakker S, Bender S, Bramon E, Collie, Crespo-Facorro DB, Hall J, Iyegbe C, Jablensky A, Kahn RS, Kalaydjieva L, et al. 2013. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet 45:1150-1159.
56. Saint-André V, Batsché E, Rachez C, Muchardt C. 2011. Histone H3 lysine 9 trimethylation and HP1γ favor inclusion of alternative exons. Nat Struct Mol Biol 18:337-344.
57. Schultz CC, Nenadic I, Riley B, Vladimirov VI, Wagner G, Koch K, Schachtzabel C, Mühleisen TW, Basmanav B, Nöthen MM, Deufel T, Kiehntopf M, Rietschel M, Reichenbach JR, Cichon S, Schlösser RGM, Sauer H. 2014. ZNF804A and Cortical Structure in Schizophrenia: In Vivo and Postmortem Studies. Schizophr Bull 40(3):532-541.
58. Schwab SG, Kusumawardhani AA, Dai N, Qin W, Wildenauer MD, Agiananda F, Amir N, Antoni R, Arsianti T, Asmarahadi A, Diatri H, Djatmiko P, Irmansyah I, Khalimah S, Kusumadewi I, Kusumaningrum P, Lukman PR, Mustar L, Nasrun MW, Naswati S, Prasetiyawan P, Semen GM, Siste K, Tobing H, Widiasih N, Wiguna T, Wulandari WD, Benyamin B, Wildenauer DB. 2013. Association of rs1344706 in the ZNF804A gene with schizophrenia in a case/control sample from Indonesia. Schizophr Res 147(1):46-52.
59. Shao L, Vawter MP. 2008. Shared gene expression alterations in schizophrenia and bipolar disorder. Biol Psychiatry 64:89-97.
60. Tao R, Cousijn H, Jaffe AE, Burnet PWJ, Edwards F, Eastwood SL, Shin JH, Lane TA, Walker MA, Maher BJ, Weinberger DR, Harrison PJ, Hyde TM, Kleinman JE. 2014. Expression of ZNF804A in Human Brain and Alterations in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder: A Novel Transcript Fetally Regulated by the Psychosis Risk Variant rs1344706. JAMA Psychiatry 71(10):1112-1120.
61. Taverna SD, Li H, Ruthenburg AJ, Allis CD, Patel DJ. 2007. How chromatin-binding modules interpret histone modifications: Lessons from professional pocket pickers. Nat Struct Mol Biol 14:1025-1040.
62. Thierry-Mieg D, Thierry-Mieg J. 2006. AceView: A comprehensive cDNA-supported gene and transcripts annotation. Genome Biol 7(Suppl 1):1-14.
63. Tsuang MT, Stone WS, Tarbox SI, Faraone SV. 2005. Validating schizotaxia and its place in studies of preventing schizophrenia by psychopharmacological intervention. Essent Psychopharmacol 6:91-103.
64. Tylee DS, Kawaguchi DM, Glatt SJ. 2013. On the outside, looking in: a review and evaluation of the comparability of blood and brain "-omes". Am J Med Genet B Neuropsychiatr Genet 162B:595-603.
65. Umeda-Yano S, Hashimoto R, Yamamori H, Okada T, Yasuda Y, Ohi K, Fukumoto M, Ito A, Takeda M. 2013. The regulation of gene expression involved in TGF-beta signaling by ZNF804A, a risk gene for schizophrenia. Schizophr Res 146(1-3):273-278.
66. Velakoulis D, Wood SJ, Smith DJ, Soulsby B, Brewer W, Leeton L, Desmond P, Suckling J, Bullmore ET, McGuire PK, Pantelis C. 2002. Increased duration of illness is associated with reduced volume in right medial temporal/anterior cingulate grey matter in patients with chronic schizophrenia. Schizophr Res 57:43-49.
67. Voineskos AN, Lerch JP, Felsky D, Tiwari A, Rajji TK, Miranda D, Lobaugh NJ, Pollock BG, Mulsant BH, Kennedy JL. 2011. The ZNF804A gene: characterization of a novel neural risk mechanism for the major psychoses. Neuropsychopharmacology 36:1871-1878.
68. Walter H, Schnell K, Erk S, Arnold C, Kirsch P, Esslinger C, Mier D, Schmitgen MM, Rietschel M, Witt SH, Nöthen MM, Cichon S, Meyer-Lindenberg A. 2011. Effects of a genome-wide supported psychosis risk variant on neural activation during a theory-of-mind task. Mol Psychiatry 16:462-470.
69. Walters JT, Corvin A, Owen MJ, Williams H, Dragovic M, Quinn EM, Judge R, Smith DJ, Norton N, Giegling I, Hartmann AM, Moller HJ, Muglia P, Moskvina V, Dwyer S, O'Donoghue T, Morar B, Cooper M, Chandler D, Jablensky A, Gill M, Kaladjieva L, Morris DW, O'Donovan MC, Rujescu D, Donohoe G. 2010. Psychosis susceptibility gene ZNF804A and cognitive performance in schizophrenia. Arch Gen Psychiatry 67:692-700.
70. Wassink TH, Epping EA, Rudd D, Axelsen M, Ziebell S, Fleming FW, Monson E, Ho BC, Andreasen NC. 2012. Influence of ZNF804a on brain structure volumes and symptom severity in individuals with schizophrenia. Arch Gen Psychiatry 69:885-892.
71. Williams HJ, Norton N, Dwyer S, Moskvina V, Nikolov I, Carroll L, Georgieva L, Williams NM, Morris DW, Quinn EM, Giegling I, Ikeda M, Wood J, Lencz T, Hultman C, Lichtenstein P, Thiselton D, Maher BS, Malhotra AK, Riley B, Kendler KS, Gill M, Sullivan P, Sklar P, Purcell S, Nimgaonkar VL, Kirov G, Holmans P, Corvin A, Rujescu D, Craddock N, Owen MJ, O'Donovan MC. 2011. Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Mol Psychiatry 16:429-441.
72. Willsey AJ, Sanders SJ, Li M, Dong S, Tebbenkamp AT, Muhle RA, Reilly SK, Lin L, Fertuzinhos S, Miller JA, Murtha MT, Bichsel C, Niu W, Cotney J, Ercan-Sencicek AG, Gockley J, Gupta AR, Han W, He X, Hoffman EJ, Klei L, Lei J, Liu W, Liu L, Lu C, Xu X, Zhu Y, Mane SM, Lein ES, Wei L, Noonan JP, Roeder K, Devlin B, Sestan N, State MW. 2013. Coexpression Networks Implicate Human Midfetal Deep Cortical Projection Neurons in the Pathogenesis of Autism. Cell 155:997-1007.
73. Wu JQ, Wang X, Beveridge NJ, Tooney PA, Scott RJ, Carr VJ, Cairns MJ. 2012. Transcriptome sequencing revealed significant alteration of cortical promoter usage and splicing in schizophrenia. PLoS One 7:e36351.
74. Yang Y, Li W, Yang G, Xiao B, Wang X, Ding M, Zhao J, Song X, Yue W, Zhang D, Zhang H, Lv L. 2013. Evaluation of the relationship between the ZNF804A single nucleotide polymorphism rs1344706 A/C variant and schizophrenia subtype in Han Chinese patients. Int J Psychiatry Med 45:269-278.
75. Zaidel DW, Esiri MM, Harrison PJ. 1997. The hippocampus in schizophrenia: lateralized increase in neuronal density and altered cytoarchitectural asymmetry. Psychol Med 27:703-713.
76. Zhang R, Yan J-D, Valenzuela RK, Lu S-M, Du X-Y, Zhong B, Ren J, Zhao S-H, Gao C-G, Wang L, Guo T-W, Ma J. 2012. Further evidence for the association of genetic variants of ZNF804A with schizophrenia and a meta-analysis for genome-wide significance variant rs1344706. Schizophr Res 141:40-47.
77. Zhang Y, Bertolino A, Fazio L, Blasi G, Rampino A, Romano R, Lee ML, Xiao T, Papp A, Wang D, Sadee W. 2007. Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc Natl Acad Sci USA 104:20552-20557.
78. Zhao W, He X, Hoadley KA, Parker JS, Hayes DN, Perou CM. 2014. Comparison of RNA-Seq by poly (A) capture, ribosomal RNA depletion, and DNA microarray for expression profiling. BMC Genomics 15:419.
79. Zhou VW, Goren A, Bernstein BE. 2011. Charting histone modifications and the functional organization of mammalian genomes. Nat Rev Genet 12:7-18.